2020
The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM). Journal Of Clinical Oncology 2020, 38: e19367-e19367. DOI: 10.1200/jco.2020.38.15_suppl.e19367.Peer-Reviewed Original ResearchOncology Care ModelDrug costsMean MedicareYale Cancer CenterMean drug costClinical trial participationSystemic cancer therapyLower drug costsCommon cancer typesChi-square testValue-based payment modelsPayment modelsClinical factorsCancer CenterTrial participationLung cancerEpisode costsCare modelCTR groupAlternative payment modelsCancer typesMean differenceCancer therapyCareEpisodes
2019
Effects of rising drug costs on efforts to control overall cost at a large academic cancer center.
Adelson K, Canavan M, Supalla S, Sedghi T, Chaudhry B, Sinanis N, Gross C. Effects of rising drug costs on efforts to control overall cost at a large academic cancer center. Journal Of Clinical Oncology 2019, 37: 2-2. DOI: 10.1200/jco.2019.37.27_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelLarge academic cancer centerAcute care useAcademic cancer centerPost-acute careMean costCancer CenterCare useDrug costsEmergency department useCost of hospitalizationMean total costValue-based payment programsCost of pharmaceuticalsCancer HospitalCancer careDepartment useTotal episodesInpatient careMedicare claimsCare modelCareEpisodesUtilization categoriesPharmaceutical spending